Do percutaneous coronary interventions protect the surgical patient?

Percutaneous coronary interventions in the diabetic patient: where do we stand?

Patient and hospital characteristics associated with inappropriate percutaneous coronary interventions.

OBJECTIVES This study sought to examine whether rates of inappropriate percutaneous coronary intervention (PCI) differ by demographic characteristics and insurance status. BACKGROUND Prior studies have found that blacks, women, and those who have public or no health insurance are less likely to undergo PCI. Whether this reflects potential overuse in whites, men, and privately insured patients...

Stroke after percutaneous coronary interventions.

n this issue of the Journal, Dukkipati et al. (1) identified the ncidence, predictors, and outcomes of stroke in patients ndergoing percutaneous coronary interventions (PCIs). troke occurred in hospital in 92 of 20,670 patients (0.3%) fter PCI, which is higher than the reported rates of 0.08% o 0.17% after diagnostic catheterization (2). The good news in this report is that brain injury hapened...

Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.

In patients with stable CAD, PCI can be considered a valuable initial mode of revascularization in all patients with objective large ischaemia in the presence of almost every lesion subset, with only one exception: chronic total occlusions that cannot be crossed. In early studies, there was a small survival advantage with CABG surgery compared with PCI without stenting. The addition of stents a...

Bleeding avoidance strategies during percutaneous coronary interventions.

Bleeding avoidance strategies for percutaneous coronary interventions continue to evolve with the availability of newer antiplatelet and anticoagulation therapies. Advances in interventional practices have altered the balance between ischemic and bleeding complications. With the availability of rapidly-acting platelet adenosine diphosphate-receptor antagonists, the need for routine glycoprotein...